Core Insights - MustGrow Biologics Corp. has authorized the grant of 1,660,315 deferred share units (DSUs) and restricted share units (RSUs) to directors, officers, and consultants, effective September 25, 2025 [1][2]. Company Overview - MustGrow Biologics Corp. is a provider of biological and regenerative agriculture solutions aimed at sustainable farming, offering eco-friendly alternatives to synthetic chemicals and fertilizers [2]. - The company has a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants, and foliar products, distributed alongside its proprietary products derived from mustard [2]. - MustGrow is focused on expanding its intellectual property portfolio, which includes approximately 109 patents, and aims to drive shareholder value through commercialization and distribution of its products [2]. - The company is publicly traded on TSXV under the ticker MGRO, with approximately 58.9 million common shares issued and outstanding and 69.1 million shares fully diluted [2].